Bottom line
How much do JDOC and HGHAX overlap?
61% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 56.5% of JDOC's assets and 56.1% of HGHAX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings JDOC and HGHAX have in common
| Holding | % of JDOC | % of HGHAX | Overlap |
|---|---|---|---|
| AbbVie, Inc. | 7.85% | 4.21% | 4.21% |
| Eli Lilly & Co. | 7.76% | 12.03% | 7.76% |
| UnitedHealth Group, Inc. | 5.85% | 4.74% | 4.74% |
| Merck & Co., Inc. | 4.82% | 6.00% | 4.82% |
| Johnson & Johnson | 4.82% | 6.75% | 4.82% |
| Thermo Fisher Scientific, Inc. | 3.73% | 1.58% | 1.58% |
| Abbott Laboratories | 3.11% | 1.82% | 1.82% |
| CVS Health Corp. | 2.83% | 2.84% | 2.83% |
| GSK plc | 2.47% | 1.17% | 1.17% |
| Stryker Corp. | 2.23% | 1.24% | 1.24% |
| Danaher Corp. | 2.16% | 2.57% | 2.16% |
| Cencora, Inc. | 2.07% | 2.46% | 2.07% |
| Intuitive Surgical, Inc. | 1.93% | 2.88% | 1.93% |
| Edwards Lifesciences Corp. | 1.73% | 2.48% | 1.73% |
| Regeneron Pharmaceuticals, Inc. | 1.60% | 2.02% | 1.60% |
| Biogen, Inc. | 1.56% | 1.36% | 1.36% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in JDOC
- AstraZeneca plc — 3.76%
- Bristol-Myers Squibb Co. — 3.57%
- Roche Holding AG — 2.82%
- Novo Nordisk A/S — 2.61%
- Argenx SE — 2.06%
- IQVIA Holdings, Inc. — 1.71%
- Teva Pharmaceutical Industries Ltd. — 1.60%
- Novartis AG — 1.60%
- Cardinal Health, Inc. — 1.51%
Only in HGHAX
- Elevance Health Inc — 3.00%
- Vertex Pharmaceuticals Inc — 2.64%
- HCA Healthcare Inc — 1.88%
- Boston Scientific Corp — 1.88%
- Agilent Technologies Inc — 1.54%
- Amgen Inc — 1.39%
- Medtronic PLC — 1.12%
- Centene Corp — 1.10%
- Dexcom Inc — 1.01%
Asset mix
| Asset type | JDOC | HGHAX |
|---|---|---|
| Stocks | 99.2% | 98.1% |
| Cash & short-term funds | — | 0.9% |
| Repurchase agreements | — | 0.4% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Country mix
| Country | JDOC | HGHAX |
|---|---|---|
| US | 75.2% | 89.6% |
| GB | 6.2% | 2.4% |
| CH | 4.4% | 0.7% |
| DK | 4.0% | 0.8% |
| JP | 2.5% | — |
| NL | 2.4% | 1.5% |
| IE | 0.4% | 2.2% |
| DE | 1.9% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do JDOC and HGHAX overlap?
What stocks do JDOC and HGHAX have in common?
Should I own both JDOC and HGHAX?
Which holds more stocks, JDOC or HGHAX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.